Clinical Trial Update: Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing two strategies to prevent restenosis after sirolimus-eluting stent placement in coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED